United States:
Doctrine Of Equivalents In US And European Patent Law
24 November 2020
Wolf, Greenfield & Sacks, P.C.
To print this article, all you need is to be registered or login on Mondaq.com.
An article written by Jonathan Roses and Alexander Lee, associate at Hoffmann Eitle,
titled "Doctrine of Equivalents in US and European Patent
Law" was published in The Pharma Letter. Read more (subscription required).
This article is the fourth in a series exploring legal issues
relevant to the life sciences industry and how they vary between
the two major jurisdictions of the United States and Europe. The
other articles included in this series are:
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from United States
Trademarks Comparative Guide
Obhan & Associates
Trademarks Comparative Guide for the jurisdiction of India, check out our comparative guides section to compare across multiple countries
2019/2020 Federal Circuit Year In Review
Gibson, Dunn & Crutcher
The easy-to-use Table of Contents is organized by substantive issue, so that the reader can easily identify all of the relevant cases bearing on the issue of choice.
Looking Ahead To Avoid Spoliation Sanctions
Pearl Cohen Zedek Latzer Baratz
A recent Federal Circuit decision denying a petition for a writ of mandamus should serve as a cautionary tale and reminder for corporate entities regarding ...
A Trademark Is Not A Copyright Or A Patent
Cowan Liebowitz & Latman PC
Although trademarks, copyrights, patents, and trade secrets all concern intangible property rights and overlap to some extent, they differ from each other significantly.
